Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2010

Feb 18, 2019

Bandages with microscopic needles could be the next big thing in vaccine delivery

Posted by in category: biotech/medical

Going to a clinic for a vaccine shot may no longer be necessary with this technology that’s now in development.

South China Morning Post February 19, 2019.

Continue reading “Bandages with microscopic needles could be the next big thing in vaccine delivery” »

Feb 18, 2019

Vaccinating Mice May Finally Slow Lyme Disease

Posted by in categories: biotech/medical, food

Killing ticks and inoculating people has failed, so researchers try immunizing mice via vaccine-laced food.

Read more

Feb 18, 2019

Lyme Disease Vaccine Candidate Reports Study Data

Posted by in category: biotech/medical

Valneva SE announced final Phase 1 study data and positive initial booster data for its Lyme Disease vaccine candidate VLA15.

“The positive final Phase 1 data for VLA15 supports and validates our plans to continue developing a safe and effective preventative vaccine that can be delivered to those who are at risk of Lyme disease infection,” said Thomas Lingelbach, CEO of Valneva.

“We look forward to continuing the development process with our recently initiated Phase 2 study. We continue to fully commit ourselves to addressing the significant unmet need for a vaccine against Lyme disease.”

Continue reading “Lyme Disease Vaccine Candidate Reports Study Data” »

Feb 18, 2019

Toxic bacteria found in microplastics on 3 different coastlines around Singapore

Posted by in category: biotech/medical

The bacteria is believed to be one of the culprits behind coral bleaching and has been known to cause wound infections in people. Learn more about the findings.

Read more

Feb 18, 2019

Advancing therapy

Posted by in category: biotech/medical

Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression. While mutations in cancer cells significantly affect drug sensitivity, it is increasingly recognized that ecological interactions between cells can also play a role.

Jacob Scott, MD, DPhil, a physician-scientist at Cleveland Clinic, is interested in learning how develop and maintain drug resistance from an eco-evolutionary perspective. He studies the evolutionary strategies that cells employ to survive even in the harshest of conditions. One area of focus of his laboratory is to examine the dynamics of sensitive versus and how they affect one another’s growth under the selective pressure of anti-cancer therapies.

“Rather than searching for a ‘silver bullet’ to wipe out all , which is unlikely, we are focused on preventing the resistant cells from taking over—from ‘winning’ every time,” Dr. Scott said. “If we can achieve this goal, we can effectively make cancer a chronic condition.”

Continue reading “Advancing therapy” »

Feb 18, 2019

Neuromelanin-sensitive MRI identified as a potential biomarker for psychosis

Posted by in categories: biotech/medical, health, neuroscience

Researchers have shown that a type of magnetic resonance imaging—called neuromelanin-sensitive MRI (NM-MRI)—is a potential biomarker for psychosis. NM-MRI signal was found to be a marker of dopamine function in people with schizophrenia and an indicator of the severity of psychotic symptoms in people with this mental illness. The study, funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, appears in the Proceedings of the National Academy of Science.

“Disturbances affecting the are associated with a host of mental and neurological disorders, such as schizophrenia and Parkinson’s disease,” said Joshua A. Gordon, M.D., Ph.D., director of NIMH. “Because of the role dopamine plays in these disorders, the ability to measure dopamine activity is critical for furthering our understanding of these disorders, including how to best diagnose and treat them.”

Neuromelanin is a dark pigment created within dopamine neurons of the midbrain—particularly in the substantia nigra, a brain area that plays a role in reward and movement. Neuromelanin accumulates over the lifespan and is only cleared away from cells following cell death, as occurs in neurodegenerative disorders such as Parkinson’s disease. Researchers have found that NM-MRI signal is lower in the substantia nigra of people with Parkinson’s disease, reflecting the cell death that occurs in these patients.

Continue reading “Neuromelanin-sensitive MRI identified as a potential biomarker for psychosis” »

Feb 18, 2019

British woman is first in the world to undergo gene therapy for most common form of blindness

Posted by in categories: biotech/medical, life extension

A British woman has become the first person in the world to undergo gene therapy for the most common cause of sight loss.

Surgeons at the John Radcliffe Hospital in Oxford inserted a synthetic gene into the left eye of Janet Osborne, 80, who suffers from age-related macular degeneration (AMD).

Around 600,000 people in the UK are affected by AMD, which affects the central part of a patient’s vision with gaps or ‘smudges’, making everyday activities like reading and recognising faces difficult.

Continue reading “British woman is first in the world to undergo gene therapy for most common form of blindness” »

Feb 18, 2019

How quantum dots supercharge farming, medicine and solar, too

Posted by in categories: biotech/medical, food, quantum physics

Circa 2018


From medical to agricultural to solar, quantum dots have uses far beyond the humble TV.

Continue reading “How quantum dots supercharge farming, medicine and solar, too” »

Feb 18, 2019

Discovering a New Form of Communication in the Brain

Posted by in categories: biotech/medical, engineering, neuroscience

Summary: Researchers have identified a previously unknown form of neural communication. They report the findings could help better the understanding of neural activity associated with specific brain processing and neurological disorders.

Source: Case Western Reserve University.

Biomedical engineering researchers at Case Western Reserve University say they have identified a previously unidentified form of neural communication, a discovery that could help scientists better understand neural activity surrounding specific brain processes and brain disorders.

Read more

Feb 18, 2019

Liz Parrish : Gene therapy advancements | BioViva | People Unlimited

Posted by in categories: biotech/medical, education, life extension

Liz talking about Rutgers, Integrated Health Systems, anti-aging vaccine(couple of years of gathering data), $75,000 single organ treatment, and potential for very affordable whole body treatment. Q&A at 32 minutes.


Liz Parrish | BioViva, presents at People Unlimited’s Ageless Education, about Gene Therapy Advancements.

Continue reading “Liz Parrish : Gene therapy advancements | BioViva | People Unlimited” »